Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
Aug 25, 2026, 11:46 AM AEST
Acrux Market Cap
Acrux has a market cap or net worth of 5.9 million as of August 26, 2026. Its market cap has increased by 3.29% in one year.
Market Cap
5.90M
Enterprise Value
7.15M
Revenue
6.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 90.77M to 5.90M, a decrease of -93.50%. That is a compound annual growth rate of -11.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 5.90M | -4.26% |
| Dec 31, 2025 | 6.16M | -53.60% |
| Dec 31, 2024 | 13.27M | 4.16% |
| Dec 29, 2023 | 12.74M | -36.43% |
| Dec 30, 2022 | 20.05M | -29.33% |
| Dec 31, 2021 | 28.37M | -18.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 12.36M |
| Immuron | 12.09M |
| AdAlta | 9.64M |
| Vectus Biosystems | 9.22M |
| Invex Therapeutics | 9.02M |
| Bio-Gene Technology | 8.32M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.40M |